Horn&Co. advised Immunorizon on the deal. Purple Biotech executed the acquisition of Immunorizon in consideration for up to $100 million. Purple Biotech Ltd. is a clinical-stage company...
Purple Biotech’s Acquisition of Immunorizon
Diagnostic Robotics’ Series B Fundraising
Horn & Co. represented Diagnostic Robotics in the deal, Amit, Pollak, Matalon & Co. advised StageOne, Migdal Insurance, Clal Insurance and Bank Hapoalim on the transaction....
Prisma Photonics’ $20 Million Capital Raising
Horn & Co. advised Prisma Photonics on the deal. ERM advised Future Energy Ventures on the transaction. Prisma Photonics Ltd. executed a $20 million raise from Insight...
Prisma Photonics’ Agreement with NYPA
Horn&Co. represented Prisma Photonics in the deal. Prisma Photonics signed an agreement with the New York Power Authority (NYPA), the largest state public utility in the...
Emergence Therapeutics’ Series A Financing Round
ARQIS has advised biotech company Emergence Therapeutics AG on the deal, while Horn&Co. advised Pontifax Ventures 6. J&A advised Bpifrance. Weitnauer advised NRW.BANK. The round was...
Oxurion’s Funding Round
Horn & Co. represented Pontifax Ventures on the deal. Pontifax Venture Capital and Kreos Capital provided €10 million debt financing to Oxurion. Oxurion is focused on...
Prisma Photonics’ Partnership Agreement with Schneider Electric
Horn & Co. represented Prisma Photonics in the deal. Schneider Electric and Prisma Photonics signed a partnership agreement to help oil and gas pipeline owners and...